LICENSE AGREEMENTLicense Agreement • March 15th, 2024 • Coherus BioSciences, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 15th, 2024 Company Industry JurisdictionTHIS LICENSE AGREEMENT (this “Agreement”), is entered into as of December 16, 2020 (the “Effective Date”), by and between Surface Oncology, Inc., a Delaware corporation having business offices at 50 Hampshire Street, Cambridge MA 02139 (“Surface”), and GLAXOSMITHKLINE INTELLECTUAL PROPERTY (No. 4) LIMITED, a company registered in England and Wales (registered number 11721880) and having business offices at 980 Great West Road, Brentford, Middlesex TW8 9GS United Kingdom (“GSK”).
LICENSE AGREEMENTLicense Agreement • December 17th, 2020 • Surface Oncology, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 17th, 2020 Company Industry JurisdictionTHIS LICENSE AGREEMENT (this “Agreement”), is entered into as of December 16, 2020 (the “Effective Date”), by and between Surface Oncology, Inc., a Delaware corporation having business offices at 50 Hampshire Street, Cambridge MA 02139 (“Surface”), and GLAXOSMITHKLINE INTELLECTUAL PROPERTY (No. 4) LIMITED, a company registered in England and Wales (registered number 11721880) and having business offices at 980 Great West Road, Brentford, Middlesex TW8 9GS United Kingdom (“GSK”).